URSODEOXYCHOLIC ACID FOR THE PREVENTION OF SYMPTOMATIC GALLSTONE DISEASE AFTER BARIATRIC SURGERY: A MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED SUPERIORITY TRIAL
Sylke Haal 1
Maimoena S.S. Guman
Thomas C.C. Boerlage 2
Yair I.Z. Acherman 3
L. Maurits de Brauw
Sjoerd Bruin
Steve M.M. de Castro 4
Jeanin van Hooft 5
Arnold W.J.M. van de Laar
Daan E. Moes 6
Manon Schouten 7
Ruben Schouten
Ellert J. van Soest
Ruben N. van Veen
Claire E.E. de Vries
Paul Fockens
Marcel G.W. Dijkgraaf
Victor E.A. Gerdes
Rogier P. Voermans
1 Amsterdam UMC, Locatie AMC/University of Amsterdam, Amsterdam, Netherlands
2 UMCU, Utrecht, Netherlands
3 Spaarne Gasthuis, Hoofddorp, Netherlands
4 OLVG, Amsterdam, Netherlands
5 Leiden University Medical Center, Leiden, Netherlands
6 Dijklander Ziekenhuis, Hoorn, Netherlands
7 Flevoziekenhuis, Almere, Netherlands
Topic
Hepatobiliary
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]